Arbutus Biopharma Corp Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in CAD from Q4 2010 to Q4 2013

Taxonomy & unit: us-gaap: CAD and USD
Description: Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary: Arbutus Biopharma Corp quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q4 2010 to Q4 2013.
Arbutus Biopharma Corp Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending December 31, 2013 was CA$117K, a 89.2% decline year-over-year.

Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (CAD)

Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2013	117K	-958K	-89.2%	Dec 31, 2013	10-K	2014-03-28
Q4 2012	1.07M	+194K	+22.1%	Dec 31, 2012	10-K	2014-03-28
Q4 2011	881K	-2.44M	-73.5%	Dec 31, 2011	20-F	2013-03-27
Q4 2010	3.32M			Dec 31, 2010	20-F	2012-03-27

* An asterisk sign (*) next to the value indicates that the value is likely invalid.